• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Surveillance After Resection of Retroperitoneal Well-Differentiated Liposarcoma: A Balancing Act Between Earlier Recurrence Detection, Patient Anxiety, and Health Care Resource Expenditure.

作者信息

Keung Emily Z, Roland Christina L

机构信息

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Ann Surg Oncol. 2020 Dec;27(Suppl 3):748-749. doi: 10.1245/s10434-020-08597-1. Epub 2020 May 14.

DOI:10.1245/s10434-020-08597-1
PMID:32409970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7666057/
Abstract
摘要

相似文献

1
ASO Author Reflections: Surveillance After Resection of Retroperitoneal Well-Differentiated Liposarcoma: A Balancing Act Between Earlier Recurrence Detection, Patient Anxiety, and Health Care Resource Expenditure.ASO作者反思：腹膜后高分化脂肪肉瘤切除术后的监测：早期复发检测、患者焦虑与医疗资源消耗之间的平衡之举
Ann Surg Oncol. 2020 Dec;27(Suppl 3):748-749. doi: 10.1245/s10434-020-08597-1. Epub 2020 May 14.
2
ASO Author Reflections: Recurrent Retroperitoneal Well-Differentiated Liposarcoma.ASO作者反思：复发性腹膜后高分化脂肪肉瘤
Ann Surg Oncol. 2019 Dec;26(Suppl 3):543-544. doi: 10.1245/s10434-018-7039-8. Epub 2018 Dec 17.
3
[Results of surgical therapy of primary and recurrent retroperitoneal liposarcoma].[原发性及复发性腹膜后脂肪肉瘤的外科治疗结果]
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:234-6.
4
[Prolonged survival in retroperitoneal liposarcoma. Apropos of a case with 27 years' survival. Prognostic value of the histological type and role of repeat surgery].[腹膜后脂肪肉瘤的长期生存。关于一例生存27年的病例。组织学类型的预后价值及再次手术的作用]
Ann Urol (Paris). 1986;20(6):397-9.
5
[Recurrent retroperitoneal liposarcoma. Presentation of a case].[复发性腹膜后脂肪肉瘤。1例病例报告]
Arch Esp Urol. 1987 Sep;40(7):517-22.
6
Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.组织学亚型和手术切缘可预测腹膜后脂肪肉瘤的复发模式和生存率。
Ann Surg. 2003 Sep;238(3):358-70; discussion 370-1. doi: 10.1097/01.sla.0000086542.11899.38.
7
ASO Author Reflections: Advances in Retroperitoneal Liposarcoma Management May Benefit from Improved Biopsy Accuracy.ASO作者反思：腹膜后脂肪肉瘤治疗进展或得益于活检准确性的提高。
Ann Surg Oncol. 2020 Oct;27(11):4582-4583. doi: 10.1245/s10434-020-08543-1. Epub 2020 May 3.
8
Successful Re-resection for Locally Recurrent Retroperitoneal Liposarcoma at Four Years After Ex Vivo Tumor Resection and Autotransplantation of the Liver: A Case Report.体外肿瘤切除及肝脏自体移植术后四年局部复发性腹膜后脂肪肉瘤的成功再次切除：一例报告
Transplant Proc. 2016 May;48(4):1215-7. doi: 10.1016/j.transproceed.2016.01.026.
9
Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous components: a case report.伴有骨肉瘤成分的腹膜后去分化脂肪肉瘤：一例报告
Int J Clin Exp Pathol. 2013 Jun 15;6(7):1427-31. Print 2013.
10
Well-differentiated abdominal liposarcoma: experience of a tertiary care center.高分化腹部脂肪肉瘤：一家三级医疗中心的经验
World J Surg Oncol. 2015 May 1;13:166. doi: 10.1186/s12957-015-0580-z.

本文引用的文献

1
Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum.评估腹膜后原发性高分化脂肪肉瘤切除术后患者的监测随访间隔的影响。
Ann Surg Oncol. 2021 Jan;28(1):570-575. doi: 10.1245/s10434-020-08582-8. Epub 2020 May 14.
2
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.软组织和内脏肉瘤：ESMO-EURACAN诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv268-iv269. doi: 10.1093/annonc/mdy321.
3
Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy.腹膜后软组织肉瘤的术后监测：肿瘤组织学在指导策略中的重要性。
J Surg Oncol. 2018 Jan;117(1):99-104. doi: 10.1002/jso.24927. Epub 2017 Nov 28.
4
Follow-up is valuable and effective: true, true and unrelated?
Ann Surg Oncol. 2000 Jan-Feb;7(1):2-3. doi: 10.1007/s10434-000-0002-4.